Association among the Prevalence of Sarcopenia without Obesity, Nonsarcopenic Obesity, Sarcopenic Obesity, and Metabolic Syndrome in Cancer Survivors : Based on Korea National Health and Nutrition Examination Survey
Copyright: © 2021 Ann & Joshua Medical Publishing Co. Ltd..
OBJECTIVE: In this study, we aimed to investigate the association among the prevalence of sarcopenia without obesity, nonsarcopenic obesity, sarcopenic obesity, and metabolic syndrome in cancer survivors using data from the 4th and 6th Korea National Health and Nutrition Examination Survey (KNHANES), a nationally representative data source.
METHODS: The 4th and 6th KNHANES was conducted in 2008-2011. Data from cancer survivors were obtained including 133 obese patients without sarcopenia, 98 obese patients with sarcopenia, and 87 patients with sarcopenia but without obesity. SPSS 22.0 was used for statistical analysis with complex sample survey modules and commands.
RESULTS: The prevalence of metabolic syndrome was 25.3% in the sarcopenia without obesity group, 61.7% in the nonsarcopenic obesity group, and 67.3% in the sarcopenic obesity group, showing the highest rate in the sarcopenic obesity group, with a significant difference among the three groups (P < 0.001).
CONCLUSIONS: In this study, the prevalence of metabolic syndrome was 25.3%, 61.7%, and 67.3% in the sarcopenia without obesity, nonsarcopenic obesity, and sarcopenic obesity groups, respectively, showing that the sarcopenic obesity group had the highest metabolic syndrome rate. Based on these results, various education programs for the prevention and treatment of metabolic syndrome should be developed for cancer patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Asia-Pacific journal of oncology nursing - 8(2021), 6 vom: 05. Nov., Seite 679-686 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Park, Yoon Jin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer survivor |
|---|
| Anmerkungen: |
Date Revised 28.04.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.4103/apjon.apjon-2116 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333284984 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333284984 | ||
| 003 | DE-627 | ||
| 005 | 20231225221339.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4103/apjon.apjon-2116 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1110.xml |
| 035 | |a (DE-627)NLM333284984 | ||
| 035 | |a (NLM)34790852 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Park, Yoon Jin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Association among the Prevalence of Sarcopenia without Obesity, Nonsarcopenic Obesity, Sarcopenic Obesity, and Metabolic Syndrome in Cancer Survivors |b Based on Korea National Health and Nutrition Examination Survey |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 28.04.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright: © 2021 Ann & Joshua Medical Publishing Co. Ltd. | ||
| 520 | |a OBJECTIVE: In this study, we aimed to investigate the association among the prevalence of sarcopenia without obesity, nonsarcopenic obesity, sarcopenic obesity, and metabolic syndrome in cancer survivors using data from the 4th and 6th Korea National Health and Nutrition Examination Survey (KNHANES), a nationally representative data source | ||
| 520 | |a METHODS: The 4th and 6th KNHANES was conducted in 2008-2011. Data from cancer survivors were obtained including 133 obese patients without sarcopenia, 98 obese patients with sarcopenia, and 87 patients with sarcopenia but without obesity. SPSS 22.0 was used for statistical analysis with complex sample survey modules and commands | ||
| 520 | |a RESULTS: The prevalence of metabolic syndrome was 25.3% in the sarcopenia without obesity group, 61.7% in the nonsarcopenic obesity group, and 67.3% in the sarcopenic obesity group, showing the highest rate in the sarcopenic obesity group, with a significant difference among the three groups (P < 0.001) | ||
| 520 | |a CONCLUSIONS: In this study, the prevalence of metabolic syndrome was 25.3%, 61.7%, and 67.3% in the sarcopenia without obesity, nonsarcopenic obesity, and sarcopenic obesity groups, respectively, showing that the sarcopenic obesity group had the highest metabolic syndrome rate. Based on these results, various education programs for the prevention and treatment of metabolic syndrome should be developed for cancer patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cancer survivor | |
| 650 | 4 | |a metabolic syndrome | |
| 650 | 4 | |a obesity | |
| 650 | 4 | |a sarcopenia | |
| 700 | 1 | |a Lee, Young Mee |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Asia-Pacific journal of oncology nursing |d 2014 |g 8(2021), 6 vom: 05. Nov., Seite 679-686 |w (DE-627)NLM256043299 |x 2347-5625 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2021 |g number:6 |g day:05 |g month:11 |g pages:679-686 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4103/apjon.apjon-2116 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2021 |e 6 |b 05 |c 11 |h 679-686 | ||